Skip to main content
Erschienen in: Cancer and Metastasis Reviews 2/2015

01.06.2015

Five critical elements to ensure the precision medicine

verfasst von: Chengshui Chen, Mingyan He, Yichun Zhu, Lin Shi, Xiangdong Wang

Erschienen in: Cancer and Metastasis Reviews | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

The precision medicine as a new emerging area and therapeutic strategy has occurred and was practiced in the individual and brought unexpected successes, and gained high attentions from professional and social aspects as a new path to improve the treatment and prognosis of patients. There will be a number of new components to appear or be discovered, of which clinical bioinformatics integrates clinical phenotypes and informatics with bioinformatics, computational science, mathematics, and systems biology. In addition to those tools, precision medicine calls more accurate and repeatable methodologies for the identification and validation of gene discovery. Precision medicine will bring more new therapeutic strategies, drug discovery and development, and gene-oriented treatment. There is an urgent need to identify and validate disease-specific, mechanism-based, or epigenetics-dependent biomarkers to monitor precision medicine, and develop “precision” regulations to guard the application of precision medicine.
Literatur
4.
Zurück zum Zitat Wu, X., Sun, X., Chen, C., Bai, C., & Wang, X. D. (2014). Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease: a preliminary study. Critical Care, 18(6), 508.PubMedCentralPubMedCrossRef Wu, X., Sun, X., Chen, C., Bai, C., & Wang, X. D. (2014). Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease: a preliminary study. Critical Care, 18(6), 508.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Chen, H., Wang, Y., Bai, C., & Wang, X. D. (2012). Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. Journal of Proteomics, 75(10), 2835–2843. doi:10.1016/j.jprot.2012.01.027.PubMedCrossRef Chen, H., Wang, Y., Bai, C., & Wang, X. D. (2012). Alterations of plasma inflammatory biomarkers in the healthy and chronic obstructive pulmonary disease patients with or without acute exacerbation. Journal of Proteomics, 75(10), 2835–2843. doi:10.​1016/​j.​jprot.​2012.​01.​027.PubMedCrossRef
9.
Zurück zum Zitat Klauschen, F., Andreeff, M., Keilholz, U., Dietel, M., & Stenzinger, A. (2014). The combinatorial complexity of cancer precision medicine. Oncoscience, 1(7), 504–509.PubMedCentralPubMed Klauschen, F., Andreeff, M., Keilholz, U., Dietel, M., & Stenzinger, A. (2014). The combinatorial complexity of cancer precision medicine. Oncoscience, 1(7), 504–509.PubMedCentralPubMed
10.
Zurück zum Zitat Dolsten, M., & Søgaard, M. (2012). Precision medicine: an approach to R&D for delivering superior medicines to patients. Clinical and Translational Medicine, 1(1), 7. doi:10.1186/2001-1326-1-7. Dolsten, M., & Søgaard, M. (2012). Precision medicine: an approach to R&D for delivering superior medicines to patients. Clinical and Translational Medicine, 1(1), 7. doi:10.​1186/​2001-1326-1-7.
11.
Zurück zum Zitat Wilky, B. A., Rudek, M. A., Ahmed, S., Laheru, D. A., Cosgrove, D., Donehower, R. C., et al. (2015). A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours. British Journal of Cancer, 112(1), 24–31. doi:10.1038/bjc.2014.515.PubMedCrossRef Wilky, B. A., Rudek, M. A., Ahmed, S., Laheru, D. A., Cosgrove, D., Donehower, R. C., et al. (2015). A phase I trial of vertical inhibition of IGF signalling using cixutumumab, an anti-IGF-1R antibody, and selumetinib, an MEK 1/2 inhibitor, in advanced solid tumours. British Journal of Cancer, 112(1), 24–31. doi:10.​1038/​bjc.​2014.​515.PubMedCrossRef
12.
13.
Zurück zum Zitat Wang, X. D., Andersson, R., Soltesz, V., & Bengmark, S. (1992). Bacterial translocation after major hepatectomy in patients and rats. Archives of Surgery, 127, 1101–1106.PubMedCrossRef Wang, X. D., Andersson, R., Soltesz, V., & Bengmark, S. (1992). Bacterial translocation after major hepatectomy in patients and rats. Archives of Surgery, 127, 1101–1106.PubMedCrossRef
14.
Zurück zum Zitat Wang, X. D., Andersson, R., Soltesz, V., Guo, W., & Bengmark, S. (1993). Water-soluble ethylhydroxyethyl cellulose prevents bacterial translocation induced by major liver resection in the rat. Annals of Surgery, 217, 155–167.PubMedCentralPubMedCrossRef Wang, X. D., Andersson, R., Soltesz, V., Guo, W., & Bengmark, S. (1993). Water-soluble ethylhydroxyethyl cellulose prevents bacterial translocation induced by major liver resection in the rat. Annals of Surgery, 217, 155–167.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Wan, X. D., & Ward, P. A. (2012). Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine. Journal of Translational Medicine, 10, 220. doi:10.1186/1479-5876-10-220.CrossRef Wan, X. D., & Ward, P. A. (2012). Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine. Journal of Translational Medicine, 10, 220. doi:10.​1186/​1479-5876-10-220.CrossRef
18.
Zurück zum Zitat Lander, E. S. (2015). Cutting the Gordian helix—regulating genomic testing in the era of precision medicine. The New England Journal of Medicine. doi:10.1056/NEJMp1501964. Lander, E. S. (2015). Cutting the Gordian helix—regulating genomic testing in the era of precision medicine. The New England Journal of Medicine. doi:10.​1056/​NEJMp1501964.
Metadaten
Titel
Five critical elements to ensure the precision medicine
verfasst von
Chengshui Chen
Mingyan He
Yichun Zhu
Lin Shi
Xiangdong Wang
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Cancer and Metastasis Reviews / Ausgabe 2/2015
Print ISSN: 0167-7659
Elektronische ISSN: 1573-7233
DOI
https://doi.org/10.1007/s10555-015-9555-3

Weitere Artikel der Ausgabe 2/2015

Cancer and Metastasis Reviews 2/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.